S&P 500   3,783.57 (-0.19%)
DOW   30,298.87 (-0.06%)
QQQ   280.67 (-0.52%)
AAPL   145.63 (-0.32%)
MSFT   248.12 (-0.31%)
META   138.05 (-1.59%)
GOOGL   100.75 (-0.88%)
AMZN   120.30 (-0.65%)
TSLA   238.25 (-4.49%)
NVDA   130.79 (-0.67%)
NIO   15.88 (-5.08%)
BABA   84.02 (-0.11%)
AMD   67.47 (-0.63%)
T   15.92 (-1.06%)
MU   54.44 (+0.89%)
CGC   3.02 (-3.82%)
F   12.43 (+0.57%)
GE   67.65 (+0.16%)
DIS   99.82 (-1.60%)
AMC   7.25 (-7.41%)
PYPL   93.49 (+0.75%)
PFE   44.05 (-0.92%)
NFLX   233.92 (-2.83%)
S&P 500   3,783.57 (-0.19%)
DOW   30,298.87 (-0.06%)
QQQ   280.67 (-0.52%)
AAPL   145.63 (-0.32%)
MSFT   248.12 (-0.31%)
META   138.05 (-1.59%)
GOOGL   100.75 (-0.88%)
AMZN   120.30 (-0.65%)
TSLA   238.25 (-4.49%)
NVDA   130.79 (-0.67%)
NIO   15.88 (-5.08%)
BABA   84.02 (-0.11%)
AMD   67.47 (-0.63%)
T   15.92 (-1.06%)
MU   54.44 (+0.89%)
CGC   3.02 (-3.82%)
F   12.43 (+0.57%)
GE   67.65 (+0.16%)
DIS   99.82 (-1.60%)
AMC   7.25 (-7.41%)
PYPL   93.49 (+0.75%)
PFE   44.05 (-0.92%)
NFLX   233.92 (-2.83%)
S&P 500   3,783.57 (-0.19%)
DOW   30,298.87 (-0.06%)
QQQ   280.67 (-0.52%)
AAPL   145.63 (-0.32%)
MSFT   248.12 (-0.31%)
META   138.05 (-1.59%)
GOOGL   100.75 (-0.88%)
AMZN   120.30 (-0.65%)
TSLA   238.25 (-4.49%)
NVDA   130.79 (-0.67%)
NIO   15.88 (-5.08%)
BABA   84.02 (-0.11%)
AMD   67.47 (-0.63%)
T   15.92 (-1.06%)
MU   54.44 (+0.89%)
CGC   3.02 (-3.82%)
F   12.43 (+0.57%)
GE   67.65 (+0.16%)
DIS   99.82 (-1.60%)
AMC   7.25 (-7.41%)
PYPL   93.49 (+0.75%)
PFE   44.05 (-0.92%)
NFLX   233.92 (-2.83%)
S&P 500   3,783.57 (-0.19%)
DOW   30,298.87 (-0.06%)
QQQ   280.67 (-0.52%)
AAPL   145.63 (-0.32%)
MSFT   248.12 (-0.31%)
META   138.05 (-1.59%)
GOOGL   100.75 (-0.88%)
AMZN   120.30 (-0.65%)
TSLA   238.25 (-4.49%)
NVDA   130.79 (-0.67%)
NIO   15.88 (-5.08%)
BABA   84.02 (-0.11%)
AMD   67.47 (-0.63%)
T   15.92 (-1.06%)
MU   54.44 (+0.89%)
CGC   3.02 (-3.82%)
F   12.43 (+0.57%)
GE   67.65 (+0.16%)
DIS   99.82 (-1.60%)
AMC   7.25 (-7.41%)
PYPL   93.49 (+0.75%)
PFE   44.05 (-0.92%)
NFLX   233.92 (-2.83%)
NASDAQ:SAVA

Cassava Sciences - SAVA News Today

$40.67
-1.05 (-2.52%)
(As of 10/5/2022 02:04 PM ET)
Add
Compare
Today's Range
$39.65
$41.47
50-Day Range
$16.33
$51.06
52-Week Range
$13.84
$100.00
Volume
24,929 shs
Average Volume
4.79 million shs
Market Capitalization
$1.63 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$44.00
Get Cassava Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for SAVA and its competitors with MarketBeat's FREE daily newsletter.



SAVA Media Mentions By Week

SAVA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SAVA
News Sentiment

0.48

0.79

Average
Medical
News Sentiment

SAVA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SAVA Articles
This Week

9

5

SAVA Articles
Average Week

SourceHeadline
marketbeat.com logo3 Alzheimer Stocks to Buy as the Race for a Cure Heats Up (SAVA)
marketbeat.com - October 5 at 2:02 PM
marketbeat.com logoCassava Sciences Target of Unusually Large Options Trading (NASDAQ:SAVA)
marketbeat.com - September 28 at 6:25 PM
msn.com logo$100 Invested In Cassava Sciences 15 Years Ago Would Be Worth This Much Today
msn.com - October 3 at 1:19 PM
msn.com logo$1000 Invested In This Stock 20 Years Ago Would Be Worth $10,000 Today
msn.com - September 30 at 5:37 PM
msn.com logoWhat’s Going on With SAVA Stock?
msn.com - September 30 at 9:58 AM
MarketBeat logoCassava Sciences (NASDAQ:SAVA) Shares Gap Up to $46.18
americanbankingnews.com - September 30 at 5:18 AM
finance.yahoo.com logoCassava Sciences, Inc. (SAVA) Stock Moves -1.76%: What You Should Know
finance.yahoo.com - September 29 at 9:29 PM
seekingalpha.com logoCassava Sciences Misses Out On The Alzheimer's Space Party
seekingalpha.com - September 29 at 6:54 PM
seekingalpha.com logoCassava Sciences Stock: Huge Returns Or Catastrophic Losses
seekingalpha.com - September 29 at 6:28 AM
finance.yahoo.com logoPain Therapeutics Stock Shows Rising Price Performance With Jump To 97 RS Rating
finance.yahoo.com - September 23 at 4:44 PM
finance.yahoo.com logoCassava Plummets After Refuting New Claims Around Data Tampering Investigation
finance.yahoo.com - September 23 at 4:44 PM
seekingalpha.com logoThe SEC Recommends Closing Cassava Sciences Investigation
seekingalpha.com - September 23 at 11:44 AM
marketwatch.com logoCassava Sciences Shares Falter on Response to SEC Probe Report >SAVA
marketwatch.com - September 23 at 11:44 AM
seekingalpha.com logoCassava: High Risk Speculative Play With Enormous Potential
seekingalpha.com - September 23 at 8:40 AM
finance.yahoo.com logoCassava Rockets After SEC Reportedly Clears It Of Tampering With Alzheimer's Data
finance.yahoo.com - September 23 at 8:40 AM
benzinga.com logoThinking about trading options or stock in Block, Cassava Sciences, Apple, Centene Corp, or General Mills?
benzinga.com - September 22 at 1:09 PM
seekingalpha.com logoThe SEC Has Officially Cleared Cassava Sciences
seekingalpha.com - September 22 at 9:05 AM
seekingalpha.com logoCassava Sciences: Trying To Manage Expectations
seekingalpha.com - September 21 at 4:59 PM
markets.businessinsider.com logoWhat's Going On With Cassava Sciences Stock?
markets.businessinsider.com - September 21 at 11:37 AM
msn.com logo$100 Invested In Cassava Sciences 10 Years Ago Would Be Worth This Much Today
msn.com - September 20 at 3:57 PM
nasdaq.com logoInteresting SAVA Put And Call Options For January 2025
nasdaq.com - September 13 at 1:22 PM
uk.investing.com logoAfter-Hours Movers: Cassava Sciences Surges on Insider Buy,...
uk.investing.com - September 13 at 3:18 AM
finance.yahoo.com logoCassava Sciences to Present at the H.C. Wainwright Global Investment Conference
finance.yahoo.com - September 8 at 6:48 PM
finance.yahoo.com logoCassava Sciences to Present at the H.C. Wainwright Global Investment Conference
finance.yahoo.com - September 8 at 9:33 AM
finance.yahoo.com logoStrong Insider Buying Makes These 2 Stocks Attractive
finance.yahoo.com - September 6 at 4:35 PM
finance.yahoo.com logoOne Way to Beat This Market Storm: Follow the Insiders
finance.yahoo.com - September 5 at 8:31 PM
seekingalpha.com logoCassava Sciences Looks As Good Of A Purchase As Ever
seekingalpha.com - September 3 at 4:34 AM
seekingalpha.com logoCassava Sciences stock jumps 10% after director buys $860K shares
seekingalpha.com - August 27 at 10:10 PM
msn.com logoInsider Richard Barry Is Betting Big on Cassava (SAVA) Stock
msn.com - August 26 at 10:44 AM
barrons.com logoBragar Eagel & Squire, P.C. Is Investigating Cassava, U.S. Bancorp, Fulgent, and Generac and Encourages Investors to Contact the Firm
barrons.com - August 22 at 1:12 PM
finance.yahoo.com logoCassava Insiders Got A Lot Richer As Shares Rebound Following Refutation of Data Manipulation Claims
finance.yahoo.com - August 18 at 5:50 PM
marketwatch.com logoCassava Sciences: Academic Journal Found No Evidence of Data Manipulation
marketwatch.com - August 18 at 10:12 AM
finance.yahoo.com logoNo Evidence of Data Manipulation in Science Publication on Simufilam
finance.yahoo.com - August 18 at 10:12 AM
seekingalpha.com logoHot Stocks: ADI leads chip stocks lower; SAVA spikes; DNUT drops on earnings; PGR new 52-week high
seekingalpha.com - August 17 at 6:32 PM
marketwatch.com logoCassava Sciences Shares Extend Rally After Board Member Sanford Robertson Increases Stake
marketwatch.com - August 17 at 1:30 PM
msn.com logoHere's How Much $1000 Invested In Cassava Sciences 5 Years Ago Would Be Worth Today
msn.com - August 17 at 1:30 PM
markets.businessinsider.com logoWhy Cassava Sciences Stock Is Ripping Higher Today
markets.businessinsider.com - August 17 at 11:30 AM
investorplace.com logoWhy Is Cassava Sciences (SAVA) Stock Up 20% Today?
investorplace.com - August 17 at 11:07 AM
msn.com logo3SAVA : Why Cassava Sciences Stock Is Soaring After Hours
msn.com - August 16 at 8:18 PM
za.investing.com logoAfter-Hours Movers: Cassava Sciences Surges on Insider Buy, Agilent Gains Post EPS
za.investing.com - August 16 at 8:18 PM
marketwatch.com logoCassava Sciences Shares Rise 23% After Board Member Sanford Robertson Increases Stake
marketwatch.com - August 16 at 8:18 PM
markets.businessinsider.com logoWhy Cassava Sciences Stock Is Soaring After Hours
markets.businessinsider.com - August 16 at 5:22 PM
seekingalpha.com logoCassava's Simufilam And Acetylcholinesterase Inhibitors: Similar Results
seekingalpha.com - August 11 at 4:52 PM
msn.com logoWhat Is Going on With Cassava Sciences (SAVA) Stock Today?
msn.com - August 8 at 6:17 PM
uk.investing.com logoCassava Sciences Reports Second Quarter Financial Results, Interim Analysis of Open-label Study
uk.investing.com - August 5 at 7:11 PM
barrons.com logoSHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Cassava Sciences, Inc. (SAVA) and Encourages Long-Term Investors to Contact the Firm
barrons.com - August 3 at 10:22 AM
finance.yahoo.com logoCassava Sciences Reports Second Quarter Financial Results for 2022, Mid-year Corporate Update and Interim Analysis of Open-label Study
finance.yahoo.com - August 3 at 10:22 AM
reuters.com logoExclusive: Cassava Sciences faces U.S. criminal probe tied to Alzheimer's drug, sources say
reuters.com - July 28 at 7:52 PM
marketwatch.com logoCassava Sciences Shares Tumble Premarket After Report of Criminal Probe >SAVA
marketwatch.com - July 27 at 10:02 PM
finance.yahoo.com logoCassava Sciences Shares Plunge After Criminal Investigation Report
finance.yahoo.com - July 27 at 5:01 PM
finance.yahoo.com logoCassava's stock dives 21% after report citing alleged criminal probe of data from Alzheimer's drug trial
finance.yahoo.com - July 27 at 5:01 PM
finance.yahoo.com logoCassava Sciences Responds to Media Reports
finance.yahoo.com - July 27 at 2:48 PM
Get Cassava Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for SAVA and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:SAVA) was last updated on 10/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.